Frank Jessen
Frank Jessen
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei uk-koeln.de
Titel
Zitiert von
Zitiert von
Jahr
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ...
Nature genetics 41 (10), 1088-1093, 2009
26792009
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ...
N Engl J Med 367, 795-804, 2012
26602012
NIA‐AA research framework: toward a biological definition of Alzheimer's disease
CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, B Dunn, SB Haeberlein, ...
Alzheimer's & Dementia 14 (4), 535-562, 2018
24292018
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
16542011
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ...
Alzheimer's & dementia 10 (6), 844-852, 2014
12292014
Defeating Alzheimer's disease and other dementias: a priority for European science and society
B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ...
The Lancet Neurology 15 (5), 455-532, 2016
10872016
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
H Hampel, R Frank, K Broich, SJ Teipel, RG Katz, J Hardy, K Herholz, ...
Nature reviews Drug discovery 9 (7), 560-574, 2010
6842010
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
6462019
Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment
F Jessen, B Wiese, C Bachmann, S Eifflaender-Gorfer, F Haller, H Kölsch, ...
Archives of general psychiatry 67 (4), 414-422, 2010
577*2010
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
4752017
Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients
D Lütjohann, A Papassotiropoulos, I Björkhem, S Locatelli, M Bagli, ...
Journal of lipid research 41 (2), 195-198, 2000
4112000
Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population
R Heun, M Bonsignore, K Barkow, F Jessen
European archives of psychiatry and clinical neuroscience 251 (2), 27-31, 2001
3522001
AD dementia risk in late MCI, in early MCI, and in subjective memory impairment
F Jessen, S Wolfsgruber, B Wiese, H Bickel, E Mösch, H Kaduszkiewicz, ...
Alzheimer's & Dementia 10 (1), 76-83, 2014
3492014
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease
L Jones, PA Holmans, ML Hamshere, D Harold, V Moskvina, D Ivanov, ...
PloS one 5 (11), e13950, 2010
3452010
24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia
A Papassotiropoulos, D Lütjohann, M Bagli, S Locatelli, F Jessen, ...
Journal of psychiatric research 36 (1), 27-32, 2002
2722002
Volume reduction of the entorhinal cortex in subjective memory impairment
F Jessen, L Feyen, K Freymann, R Tepest, W Maier, R Heun, HH Schild, ...
Neurobiology of aging 27 (12), 1751-1756, 2006
2652006
The future of Alzheimer's disease: the next 10 years
H Hampel, D Prvulovic, S Teipel, F Jessen, C Luckhaus, L Frölich, ...
Progress in neurobiology 95 (4), 718-728, 2011
2612011
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies
LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ...
Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015
2572015
A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats
J van der Zee, I Gijselinck, L Dillen, T Van Langenhove, J Theuns, ...
Human mutation 34 (2), 363-373, 2013
2502013
Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐and high‐CSF Aβ40 load
J Wiltfang, H Esselmann, M Bibl, M Hüll, H Hampel, H Kessler, L Frölich, ...
Journal of neurochemistry 101 (4), 1053-1059, 2007
2442007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20